Paper Details

  1. Home
  2. Paper Details

The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.

Author: LuDan, ShengJie, ZhangJian Ping, ZhangWei Yuan

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The LNG-IUS appears to be an effective method in alleviating dysmenorrhea associated with adenomyosis during 3 years.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The objective of this study was to evaluate the efficacy and side effects of the levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of moderate or severe dysmenorrhea associated with adenomyosis for a 3-year follow-up period. STUDY DESIGN: The LNG-IUS was inserted i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.contraception.2008.11.004

データ提供：米国国立医学図書館（NLM）

The LNG-IUS: A Treatment Option for Dysmenorrhea Associated with Adenomyosis

In the field of gynecology, adenomyosis, a condition characterized by the presence of endometrial tissue within the uterine wall, can cause significant pain and discomfort. This study explores the efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) in treating dysmenorrhea associated with adenomyosis. The authors followed 94 women for three years, documenting their experiences with the LNG-IUS. The results highlight the effectiveness of the LNG-IUS in alleviating dysmenorrhea and reducing uterine volume, providing a valuable long-term treatment option for women with this condition.

A Long-Term Solution for Dysmenorrhea

The research provides compelling evidence for the efficacy of the LNG-IUS in treating dysmenorrhea associated with adenomyosis. The significant reduction in dysmenorrhea scores and uterine volume observed over three years suggests that the LNG-IUS offers a sustainable solution for managing this condition. The study provides valuable insights for clinicians seeking to provide long-term relief for women struggling with adenomyosis.

Improving Quality of Life for Women

This study underscores the importance of providing women with effective treatment options for adenomyosis. By alleviating dysmenorrhea and reducing uterine volume, the LNG-IUS can significantly improve quality of life for women with this condition. Just as a camel adapts to the challenges of the desert, women with adenomyosis can find relief and empowerment through effective treatment options.

Dr.Camel's Conclusion

This study demonstrates the effectiveness of the LNG-IUS in treating dysmenorrhea associated with adenomyosis. The research highlights the long-term benefits of this treatment option, providing hope for women seeking relief from this debilitating condition. Just as a camel navigates the vast desert landscape, we must explore and embrace innovative treatment options to improve the lives of women facing gynecological challenges.

Date :
  1. Date Completed 2009-05-14
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

19185671

DOI: Digital Object Identifier

10.1016/j.contraception.2008.11.004

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.